The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Ambulatory heart rate reduction after catheter-based renal denervation in hypertensive patients not receiving anti-hypertensive medications: data from SPYRAL HTN-OFF MED, a randomized, sham-controlled, proof-of-concept trial
Abstract
AIMS: The randomized sham-controlled SPYRAL HTN-OFF MED trial demonstrated that renal denervation (RDN) using a multi-electrode catheter lowers ambulatory blood pressure (BP) in non-medicated hypertensive patients. The current report describes the effects of RDN on heart rate (HR) in this population. METHODS AND RESULTS: Patients were enrolled with an office systolic BP (SBP) of ≥150 mmHg and <180 mmHg, office diastolic BP (DBP) of ≥90 mmHg, and a mean ambulatory SBP of ≥140 mmHg and <170 mmHg. Patients were drug naïve or removed from their anti-hypertensive medications. Eighty patients were randomized 1:1 to RDN or sham procedure. This post hoc analysis examines the effect at 3 months of RDN on HR and of high baseline 24-h HR on BP and HR changes. There was a significant reduction in 24-h HR at 3 months for the RDN group (-2.5 b.p.m.) compared with sham (-0.2 b.p.m.), P = 0.003 (analysis of covariance). Mean baseline-adjusted treatment differences were significantly different between groups at 3 months for average morning HR (-4.4 b.p.m., P = 0.046) and minimum morning HR (-3.0 b.p.m., P = 0.026). RDN patients with baseline 24-h HR above the median (73.5 b.p.m.) had significant reductions in average ambulatory SBP (-10.7 mmHg difference, P = 0.001) and DBP (-7.5 mmHg, P < 0.001), whereas BP changes in RDN patients with below-median HRs were not significant. CONCLUSION: Average and minimum morning HR were significantly reduced at 3 months for RDN compared with sham patients. A baseline 24-h HR above the median predicted greater BP reductions and may allow physicians to select patients likely to respond to the procedure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another post hoc analysis of the same trial found that patients with a baseline heart rate greater than the median (73.5 bpm) had a larger decrease in SBP and diastolic blood pressure (DBP) following RDN than those with a baseline heart rate below the median93.”
From Renal nerves in physiology, pathophysiology and interoception (2025) · cites this paper as [93]
Citations
Cites
A Controlled Trial of Renal Denervation for Resistant Hypertension
Bhatt, D. L., Kandzari, D. E., O'Neill, W. W., D'Agostino, R., Flack, J. M., Katzen, B. T., Leon, M. B., Liu, M., Mauri, L., Negoita, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402670 · Cited by 2,186
Self-citationHeart rate and cardiovascular mortality: The Framingham study
Kannel, W. B., Kannel, C., Paffenbarger, R. S., & Cupples, L. A. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90666-1 · Cited by 1,290
Böhm, M., Swedberg, K., Komajda, M., Borer, J. S., Ford, I., Dubost-Brama, A., Lerebours, G., & Tavazzi, L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61259-7 · Cited by 1,099 · cited 2×
“Heart rate is a predictor of cardiovascular outcomes in various cardiovascular and non-cardiovascular conditions,(23,25) including in the general population,(3) in hypertension,(4,5) in high-risk vascular patients after stroke or myocardial infarction(7) and in heart failure.(8) Diagnostic data from implantable cardia…”
Self-citationSega, R., Facchetti, R., Bombelli, M., Cesana, G., Corrao, G., Grassi, G., & Mancia, G. (2005) · Circulation · doi:10.1161/01.cir.0000160923.04524.5b · Cited by 1,009 · cited 3×
“Herein, we report that in patients with a HR above the median as a potential sign of sympathetic activation, higher HR was predictive of reduction in average daytime SBP, daytime DBP, and office SBP.”
InfluentialTownsend, R. R., Mahfoud, F., Kandzari, D. E., Kario, K., Pocock, S., Weber, M. A., Ewen, S., Tsioufis, K., Tousoulis, D., Sharp, A. S. P., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32281-x · Cited by 752
Self-citationInfluence of heart rate on mortality among persons with hypertension: The Framingham Study
Gillman, M. W., Kannel, W. B., Belanger, A., & D'Agostino, R. B. (1993) · American Heart Journal · doi:10.1016/0002-8703(93)90128-v · Cited by 621
Krum, H., Schlaich, M. P., Sobotka, P. A., Böhm, M., Mahfoud, F., Rocha-Singh, K., Katholi, R., & Esler, M. D. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62192-3 · Cited by 619
Self-citationAzizi, M., Sapoval, M., Gosse, P., Monge, M., Bobrie, G., Delsart, P., Midulla, M., Mounier-Véhier, C., Courand, P.-Y., Lantelme, P., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61942-5 · Cited by 519
Esler, M. D., Böhm, M., Sievert, H., Rump, C. L., Schmieder, R. E., Krum, H., Mahfoud, F., & Schlaich, M. P. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu209 · Cited by 259
Self-citationResting Heart Rate: Risk Indicator and Emerging Risk Factor in Cardiovascular Disease
Böhm, M., Reil, J.-C., Deedwania, P., Kim, J. B., & Borer, J. S. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.09.016 · Cited by 236 · cited 1×
“However, the increase of HR and BP during exercise is not affected by catheter-based RDN treatment for hypertension.(23,24)”
Self-citation
Cited by
Böhm, M., Kario, K., Kandzari, D. E., Mahfoud, F., Weber, M. A., Schmieder, R. E., Tsioufis, K., Pocock, S., Konstantinidis, D., Choi, J. W., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30554-7 · Cited by 606
Self-citationValensi, P. E. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01356-w · Cited by 164
“Heart rate is also significantly reduced through renal denervation [108].”
BackgroundDevice-based therapies for arterial hypertension
Lauder, L., Azizi, M., Kirtane, A. J., Böhm, M., & Mahfoud, F. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0364-1 · Cited by 132
Self-citation(2022) · PubMed Central · doi:10.6515/acs.202205_38(3).20220321a · Cited by 117
Arterial hypertension – Clinical trials update 2021
Ghorani, H. A., Götzinger, F., Böhm, M., & Mahfoud, F. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.09.007 · Cited by 154
“In this context, 24-h heart rate in the SPYRAL HTN-OFF MED trial [47] and baseline nighttime SBP including its variability in the DENER-HTN trial [48] predicted future BP reductions after RDN [49].”
Self-citation
Metadata
- Authors
- Böhm, M., Mahfoud, F., Townsend, R. R., Kandzari, D. E., Pocock, S., Ukena, C., Weber, M. A., Hoshide, S., Patel, M., Tyson, C. C., Weil, J., Agdirlioglu, T., Fahy, M., & Kario, K.
- Affiliations
- Universitätsklinikum des Saarlandes (DE)
- University of Pennsylvania (US)
- Piedmont Atlanta Hospital (US)
- London School of Hygiene & Tropical Medicine (GB)
- SUNY Downstate Health Sciences University (US)
- Jichi Medical University (JP)
- Duke Medical Center (US)
- Sana Kliniken AG (DE)
- Medtronic PLC, Santa Rosa, CA, USA
- Department of Cardiovascular Medicine, Jichi Medical University School of Medicine, Tochigi, Tochigi-ken, Japan
- Corresponding author
- Böhm, Michael
- ORCID
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-01-04
- Volume
- 40
- Issue
- 9
- Pages
- 743-751
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2908097331
- Cited by
- 87
- References
- 26
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 3 · 2023: 17 · 2022: 16 · 2021: 17 · 2020: 14 · 2019: 11
- FWCI
- 8.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- European Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medtronic
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- renal denervation, heart rate, ambulatory blood pressure, hypertension, drug-naive patients, multielectrode catheter
- MeSH terms
- Proof of Concept Study, Adult, Aged, Female, Heart Rate, Humans, Hypertension, Male, Middle Aged, Renal Artery, Sympathectomy, Treatment Outcome, Catheter Ablation, Blood Pressure Monitoring, Ambulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ambulatory heart rate reduction after catheter-based renal denervation in hypertensive patients not receiving anti-hypertensive medications: data from SPYRAL HTN-OFF MED, a randomized, sham-controlled, proof-of-concept trial. https://app.cochat.ai/papers/10.1093/eurheartj/ehy871
- The paper
- Böhm, M., Mahfoud, F., Townsend, R. R., Kandzari, D. E., Pocock, S., Ukena, C., Weber, M. A., Hoshide, S., Patel, M., Tyson, C. C., Weil, J., Agdirlioglu, T., Fahy, M., & Kario, K. (2019). Ambulatory heart rate reduction after catheter-based renal denervation in hypertensive patients not receiving anti-hypertensive medications: data from SPYRAL HTN-OFF MED, a randomized, sham-controlled, proof-of-concept trial. European Heart Journal. https://doi.org/10.1093/eurheartj/ehy871
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.